Patent · US Active

Protein conjugates

US12344645B2 · kind B2 · utility

0Cited by

58References

20Claims

0Family size

Assignee

POLARIS GROUP · KY

Inventors

Robert Almassy · Vista, US
Elena Brin · San Diego, US
Richard E. Showalter · Lakeside, US
James A. Thomson · Madison, US

Key dates

Filing date	Mar 29, 2018
Grant date	Jul 1, 2025
Priority date	—
Expiry date	Jul 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y305/03006
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are conjugates of an arginine deiminase (ADI) and a Tumor Necrosis Factor (TNF) superfamily ligand, and related compositions and methods of use thereof. Also provided are conjugates of a hexameric polypeptide and a trimeric polypeptide, conjugates of a first and second trimeric polypeptide, and related compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.